Study of MK-3475 (Pembrolizumab) in Patients With Microsatellite Unstable (MSI) Tumors (Cohort D)

Clinical trial NCT04098068 · COMPLETED

Trial details

NCT number: NCT04098068
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

High Tumor Mutation Burden High TMB (Tumor Mutation Burden)MSS (Microsatellite Stable)

Start date: 2018-01-25
Primary completion: 2022-05-15
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.